Wound dressing produced by an electrospinning method for the treatment of pressure ulcers

The electrospun wound dressing with a superabsorbent polymer and antibacterial coating addresses the limitations of traditional dressings by maintaining moisture balance and preventing infection, promoting healing and reducing the need for frequent changes.

WO2026235669A1PCT designated stage Publication Date: 2026-11-12ONDOKUZ MAYIS UNIVERSITESI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/TR2026/050501
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-05-07
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Traditional wound dressings for pressure ulcers fail to maintain moisture balance, are insufficient for anatomically challenging areas, lack antibacterial protection, and require frequent changes, leading to infection risk, discomfort, and increased healthcare workload.

Method used

A wound dressing with a superabsorbent polymer layer and antibacterial coating, produced by electrospinning, that absorbs excess fluid, maintains moisture balance, prevents bacterial growth, and adapts to body contours, reducing the need for frequent changes.

Benefits of technology

The dressing effectively manages moisture, prevents infection, accelerates healing, and enhances patient comfort by maintaining a stable, sterile environment with reduced dressing frequency.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention has been developed to prevent tissue deformation occurring in pressure ulcers, to reduce the risk of infection by preventing bacteria formation on the wound surface, and to accelerate the natural healing process of the wound; and it relates to the production of a multi-layered wound dressing equipped with superabsorbent polymer fiber structures containing antibacterial additives, coated on a natural hemp woven surface by an electrospinning method; said dressing is a wound dressing produced by an electrospinning method for the treatment of pressure ulcers, which ensures moisture balance by trapping the exudate within its body thanks to its high fluid retention capacity, contributes to keeping the wound clean by suppressing microorganism formation with its antimicrobial coating, and provides effectiveness both in infection control and in the healing process by delicately adapting to the wound surface thanks to its biocompatible, flexible structure.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] WOUND DRESSING PRODUCED BY AN ELECTROSPINNING METHOD FOR THE TREATMENT OF PRESSURE ULCERS

[0002] Technical Field

[0003] The invention relates to a wound dressing produced by an electrospinning method for the treatment of pressure ulcers, which is developed by applying a polymer fiber coating using the electrospinning method to be used particularly in the treatment of pressure ulcers occurring during long-term bedrest, and which has an antibacterial effect and superabsorbent properties, in the field of health and medical material technologies.

[0004] Background of the Invention

[0005] Pressure ulcers are serious skin lesions frequently encountered in immobile patients that occur when skin and subcutaneous tissues are subjected to prolonged pressure during long-term bedrest. These lesions open up as wounds when they reach a certain level. High friction, which keeps the skin tense, high body temperature, and wet skin all facilitate the formation of wounds. A pressure ulcer can form within 24-48 hours in a patient who remains in a constant position, and if necessary precautions are not taken and immediate intervention is not provided, it can progress rapidly. Especially in elderly, paralyzed, or intensive care patients, these wounds carry a risk of infection, and their healing process is also highly difficult. Traditional bandages and wound dressings used in the treatment of pressure ulcers today are generally limited to removing moisture or closing the wound; they do not actively contribute to the healing process. In standard products, the wound's moisture balance cannot be adequately maintained, leading to excessively humid or dry environments that slow wound healing or increase the risk of infection.

[0006] Some advanced wound dressings currently used remain insufficient for lesions in anatomically challenging areas and for those with high wound fluid (exudate) production, such as pressure ulcers. Gauze, cotton dressings, and foam-based dressings can absorb fluid to a limited extent, thereby allowing moisture to accumulate around the wound and, consequently, leading to skin irritation and bacterial contamination. When moisture balance is not maintained, these products can cause the wound to become excessively humid or dry out, adversely affecting tissue reconstruction and the granulation process. In addition, because many commercialbandages lack antibacterial protection, the risk of infection increases, and the healing process is prolonged. Existing products cannot fully adapt to curved or mobile anatomical regions, such as the heel, hip bony prominence, and sacrum, and they displace or lift their edges over time, reducing the effectiveness of the dressing. In addition, some traditional bandages used on elderly individuals with sensitive skin can lead to irritation, redness, itching, and contactdependent skin damage. Due to their low fluid retention capacity, they require frequent dressing changes, which both decrease patient comfort and create a workload for healthcare personnel. Additionally, the need for frequent dressing changes creates an economic burden by increasing the amount of material used and the cost. On the other hand, the excessive adhesiveness of some wound dressings may cause re-injury to healing tissues during removal, further prolonging the treatment process.

[0007] The subject matter invention eliminates the above-mentioned disadvantages by starting from the state of the art. Synergistic effects resulting from the combination of all materials explained in the wound dressing subject to the invention are observed, and these synergistic effects are fundamentally based on the fact that different materials work together to further increase the individual effects of each component. Improved wound healing, more effective infection control, increased antimicrobial effect, high mechanical durability, and the provision of a more effective and efficient wound care solution achieved in the wound dressing subject to the invention, due to this synergistic effect, are considered technical advantages.

[0008] Thanks to the superabsorbent polymer layer in the dressing structure, it rapidly absorbs the fluid (exudate) produced by the wound and traps it within. This situation both helps balance moisture around the wound and reduces the risk of the wound tissue becoming infected. Thanks to the polymer's high absorbency, fluid accumulation in the wound bed is prevented, and the wound periphery remains dry. Furthermore, the antibacterial coating of the dressing helps keep the wound sterile by preventing bacterial growth. Moreover, with its flexible, soft structure, the dressing fully covers the area under pressure; it does not open or become displaced. This feature increases patient comfort while reducing the frequency of dressing changes and lightening the workload for both the patient and the healthcare worker.

[0009] The differences and advantages of the invention over existing products are as follows:

[0010] • It comprises a superabsorbent polymer-coated layer with a high fluid-absorption capacity.

[0011] • It prevents leakage or irritation in the surrounding area by trapping the wound fluid (exudate) within itself.

[0012] • It prevents the proliferation of microorganisms thanks to the antibacterial coating.

[0013] • It has a flexible structure that adapts to pressure areas, easily conforms to shape, and remains stable.

[0014] • It accelerates healing by optimizing moisture balance.

[0015] • It is sufficient to be changed less frequently compared to existing bandages, which provides advantages in both cost and labor.

[0016] • It is lightweight, soft, and skin-friendly; it does not cause allergies or irritation.

[0017] Detailed Description of the Invention

[0018] The invention relates to a wound dressing produced by an electrospinning method for the treatment of pressure ulcers, and is described solely for a better understanding of the subject matter and in a manner that will not create any limiting effect. The subject matter invention consists of the following parts:

[0019] • a hemp woven surface produced from natural fiber, which covers the wound and prevents its contact with the external environment,

[0020] • a superabsorbent polymer fiber layer applied on the woven surface by an electrospinning method, which absorbs the exudate and keeps it within its body,

[0021] • an antibacterial additive incorporated into the polymer structure, which prevents microbial proliferation,

[0022] • PULL / PVA / MMT and HA / PVA / MMT-based solutions, which are used to form this fibrous structure of the wound dressing.

[0023] The invention is an antibacterial superabsorbent polymer (SAP) wound dressing coated on a hemp woven surface, comprising multiple functional layers, designed to provide both physical and chemical protection by leveraging the synergistic effects of polymers of varying

[0024] characteristics, antimicrobial additives, and carrier matrices. The invention comprises two different solution systems prepared by electrospinning (electrodeposition): PULL / PVA / MMT / Turpentine and HA / PVA / MMT / Turpentine. MMT (montmorillonite clay mineral), a common component in both solutions, increases mechanical durability in the region contacting the wound while acting as a physical barrier preventing bacteria from passing through the dressing. At the same time, biocompatible polymers such as PULL (pullulan) and HA (hyaluronic acid) help maintain tissue moisture by preserving the skin's water balance, thereby stimulating cell regeneration.

[0025] During electrospinning, solutions are sprayed under high voltage, resulting in fine fibers being deposited onto a conductive ground. This fine fiber structure imparts high surface area, air permeability, and moisture-absorbing properties to the dressing. Thus, excess exudate (fluid) on the wound surface is rapidly absorbed, and the moisture balance of the wound is kept at an ideal level. Turpentine oil incorporated into the dressing acts as a natural antimicrobial agent, helping reduce the risk of infection. Turpentine also exhibits analgesic and antiinflammatory effects on the wound surface.

[0026] In addition, surfactants (emulsifiers) such as Span 80 (sorbitan monooleate) and Tween 20 (polysorbate 20) added to the solution ensure homogeneous dispersion of the components and increase both the mechanical integrity and the bioavailability of the obtained polymer coating. Thanks to these emulsifiers, the uniform distribution of turpentine oil within the polymer matrix is ensured, enabling an even effect at every point.

[0027] 1. Preparation of solutions for electrospinning:

[0028] a) PULL / PVA / MMT / Turpentine solution

[0029] MMT powder is dispersed in double-distilled water using magnetic stirring at 300 rpm for 1 hour at room temperature. After 1 hour, PVA is added to the solution, heated to 80°C, and magnetically stirred at 300 rpm for 2 hours; the solution is then cooled to room temperature. PULL powder is prepared by separately dissolving it in double-distilled water using magnetic stirring for 2 hours at room temperature. 14% PULL / PVA / MMT solutions are prepared to have a PULL / PVA mass ratio of 60 / 40. The MMT ratio in the total mixture is 5% by weight. At room temperature, the PVA / MMT mixture is stirred with PULL for 1 hour; during stirring, turpentine in proportions of 100 pl, 200 pl, 300 pl, and 500 pl is added to the separate mixtures alongwith 1% (w / w) of Span 80 and 1% (w / w) of Tween 20, and stirred at 700 rpm at 27°C until a clear mixture is obtained.

[0030] b) HA / PVA / MMT / Turpentine solution

[0031] MMT powder is dispersed in double-distilled water using magnetic stirring at 300 rpm for 1 hour at room temperature. After 1 hour, PVA is added to the solution, heated to 80°C, and magnetically stirred at 300 rpm for 2 hours; the solution is then cooled to room temperature. HA is prepared by separately dissolving it in double-distilled water using magnetic stirring for 2 hours at room temperature. 14% HA / PVA / MMT solutions are prepared to have an HA / PVA mass ratio of 60 / 40. The MMT ratio in the total mixture is 5% by weight. At room temperature, the PVA / MMT mixture is stirred with HA for 1 hour; during stirring, turpentine in proportions of 100 pl, 200 pl, 300 pl, and 500 pl is added to the separate mixtures along with 1% (w / w) of Span 80 and 1% (w / w) of Tween 20, and stirred at 700 rpm at 27°C until a clear mixture is obtained.

[0032] 2. Electrospinning:

[0033] Electrospinning is performed by separately drawing the mixtures into a 10 ml syringe at 15-30 kV with a distance of 15 cm. The solution flow rate is adjusted in a controlled manner within the range of 0.01 ml / min to 0.05 ml / min by a syringe pump. PULL / PVA / MMT / Turpentine and HA / PVA / MMT / Turpentine coatings are provided by adhering hemp weaving onto an electrically grounded aluminum sheet.

[0034] A reference number follows the technical features mentioned in each claim, and these reference numbers have been used solely to facilitate the understanding of the claims; therefore, they should not be considered as limiting the scope of any of the elements indicated with these reference numbers for exemplary purposes. A person skilled in the art can also implement the innovation presented in the invention by using similar configurations and / or apply this configuration to other fields used for similar purposes in the relevant art. Therefore, it is obvious that such configurations will fail to meet the criteria of novelty and, in particular, to exceed the state of the art.

Claims

CLAIMS1. The invention relates to a wound dressing produced by an electrospinning method for the treatment of pressure ulcers, characterized in that it comprises:• a hemp-woven surface produced from natural fiber, which covers the wound and prevents its contact with the external environment,• a superabsorbent polymer fiber layer applied on the woven surface by an electrospinning method, which absorbs the exudate and keeps it within its body,• an antibacterial additive incorporated into the polymer structure, which prevents microbial proliferation,• PULL / PVA / MMT and HA / PVA / MMT-based solutions used to form this fibrous structure of the wound dressing.

2. A superabsorbent polymer-coated wound dressing for pressure ulcers according to Claim 1, characterized in that it comprises a polymer fiber layer that draws the fluid (exudate) on the wound surface into its body and traps it, thereby preventing moisture accumulation in the surroundings and reducing irritation around the wound.

3. A superabsorbent polymer-coated wound dressing for pressure ulcers according to Claim 1 or 2, characterized in that it comprises montmorillonite (MMT) clay mineral present in polymer solutions, which imparts mechanical durability to the dressing and acts as a physical barrier against the passage of bacteria.

4. A superabsorbent polymer-coated wound dressing for pressure ulcers according to any one of Claims 1 to 3, characterized in that it comprises biocompatible polymers such as PULL (pullulan) and HA (hyaluronic acid), which stimulate cell regeneration by preserving the moisture balance on the skin surface.

5. A superabsorbent polymer-coated wound dressing for pressure ulcers according to any one of Claims 1 to 4, characterized in that the naturally sourced turpentine oil incorporated into the solution has antibacterial, analgesic, and anti-inflammatory effects.

6. A superabsorbent polymer-coated wound dressing for pressure ulcers according to any one of Claims 1 to 5, characterized in that it comprises Span 80 (sorbitan monooleate) and Tween20 (polysorbate 20) surfactants that ensure the homogeneous dispersion of turpentine oil within the polymer matrix.

7. A superabsorbent polymer-coated wound dressing for pressure ulcers according to any one of Claims 1 to 6, characterized in that it has a flexible and lightweight structure that allows it to remain stable without being displaced by adapting to anatomically challenging areas (such as the heel, hip, sacrum).

8. A superabsorbent polymer-coated wound dressing for pressure ulcers according to any one of Claims 1 to 7, characterized in that it comprises an antibacterial additive that prevents the wound from becoming infected by hindering microbial proliferation.

9. A production method of a superabsorbent polymer-coated wound dressing for pressure ulcers according to Claim 1, characterized in that it involves adjusting the solution flow rate between 0.01 ml / min and 0.05 ml / min during the electrospinning process and performing coating on the hemp woven surface by applying it from a distance of 15 cm with a voltage of 15-30 kV.